Neurotoxicity of nicotinamide derivatives: their role in the aetiology of Parkinson's disease.
Willets
J M
JM
Molecular Toxicity Group, University of Leicester, Glenfield General Hospital.
Lunec
J
J
Williams
A C
AC
Griffiths
H R
HR
D015655:1-Methyl-4-phenylpyridinium / Q000633:toxicity; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D007536:Isomerism; D007700:Kinetics; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D009447:Neuroblastoma; D009498:Neurotoxins / Q000633:toxicity*; D009536:Niacinamide / Q000031:analogs & derivatives* / Q000633:toxicity*; D010300:Parkinson Disease / Q000209:etiology*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced*; D051381:Rats; D012402:Rotenone / Q000633:toxicity; D014407:Tumor Cells, Cultured
D009498:Neurotoxins; D012402:Rotenone; D009536:Niacinamide; D007770:L-Lactate Dehydrogenase; D015655:1-Methyl-4-phenylpyridinium; C008472:N-methylnicotinamide